Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade ...

In early December 2025, Twist Bioscience launched research-grade Plasmid DNA Preps with animal origin-free and endotoxin-free options tailored to stringent preclinical study requirements. This move ...

Twist Bioscience (TWST) just rolled out research grade Plasmid DNA Preps tailored for pre clinical pharma and biotech work, a small but telling move that helps explain the recent uptick in the stock.

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...

Discover expert strategies for selecting optimal labels for single particle tracking in super-resolution microscopy ...

At an apple processing facility in Watsonville, the 2025 UC Santa Cruz iGEM team took a deep dive into mycotoxins in food, ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

This important study reveals that mitotic release of an ER-microtubule tether is critical for normal mitotic progression. Manipulating CLIMP63 phosphorylation, the authors provide convincing evidence ...

A new scientific review has uncovered how complex microbial communities, including those in the human gut and the natural environment, act as powerful ...

Sempresto, Inc., a medical device company pioneering smartphone integrated rescue drug delivery, today announced the acquisition of Alerje's mobile device integrated auto-injector platform, including ...

Certain today announced the launch of Event Advisor, a new AI-native product that delivers personalized recommendations to event attendees while converting their engagement into real-time buying ...